GlassScriptPhysician profile
Harish Shah
NPI 1619952181
$3,081.20
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,766 · 2020: $22.50 · 2023: $274 · 2024: $18.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $292.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $292.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $374.67 | 2019 | |
| Janssen Biotech, INC. | $305.72 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $267.90 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $237.06 | 2019 | |
| Novartis Pharmaceuticals Corporation | $236.44 | 2019 | |
| Abbvie INC. | $165.85 | 2019-2023 | Vraylar |
| Eisai INC. | $165.07 | 2019 | |
| Genzyme Corporation | $164.69 | 2019 | |
| Tesaro, INC. | $150.57 | 2019 | |
| Boston Scientific Corporation | $150.00 | 2023 | Watchman Flx |
| Celgene Corporation | $147.65 | 2019 | |
| Amgen INC. | $115.83 | 2019 | |
| Kite Pharma, INC. | $111.25 | 2019 | |
| Pfizer INC. | $82.46 | 2019 | |
| Merck Sharp & Dohme LLC | $79.89 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $40.58 | 2019 | |
| Astellas Pharma US INC | $40.03 | 2019 | |
| Daiichi Sankyo INC. | $37.51 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $29.60 | 2019 | |
| Seagen INC. | $27.39 | 2019 | |
| Gilead Sciences, INC. | $27.21 | 2019 | |
| Lilly USA, LLC | $25.89 | 2019 | |
| Exelixis INC. | $19.97 | 2019 | |
| Biocon Biologics INC | $18.02 | 2024 | Ogivri |
| Genentech USA, INC. | $15.00 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.00 | 2019 | |
| Amag Pharmaceuticals, INC. | $14.98 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $14.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harish Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.